PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
88.67%
Revenue growth 50-75% of CRK's 129.75%. Martin Whitman would scrutinize if slower growth is temporary.
1.04%
Cost growth less than half of CRK's 514.35%. David Dodd would verify if cost advantage is structural.
189.76%
Gross profit growth exceeding 1.5x CRK's 58.69%. David Dodd would verify competitive advantages.
53.58%
Margin expansion while CRK shows decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
-24.18%
G&A reduction while CRK shows 31.13% growth. Joel Greenblatt would examine efficiency advantage.
No Data
No Data available this quarter, please select a different quarter.
-200.00%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-26.34%
Both companies reducing operating expenses. Martin Whitman would check industry trends.
-10.15%
Total costs reduction while CRK shows 29.64% growth. Joel Greenblatt would examine advantage.
-6.52%
Interest expense reduction while CRK shows 0.00% growth. Joel Greenblatt would examine advantage.
-0.29%
D&A reduction while CRK shows 10.19% growth. Joel Greenblatt would examine efficiency.
259.24%
EBITDA growth 50-75% of CRK's 500.62%. Martin Whitman would scrutinize operations.
111.54%
EBITDA margin growth below 50% of CRK's 273.71%. Michael Burry would check for structural issues.
1037.82%
Operating income growth exceeding 1.5x CRK's 627.88%. David Dodd would verify competitive advantages.
503.08%
Operating margin growth exceeding 1.5x CRK's 216.82%. David Dodd would verify competitive advantages.
-136.49%
Other expenses reduction while CRK shows 52.15% growth. Joel Greenblatt would examine advantage.
2520.00%
Pre-tax income growth exceeding 1.5x CRK's 363.27%. David Dodd would verify competitive advantages.
1288.68%
Pre-tax margin growth exceeding 1.5x CRK's 214.59%. David Dodd would verify competitive advantages.
2383.33%
Tax expense growth less than half of CRK's 21644.93%. David Dodd would verify if advantage is sustainable.
2541.03%
Net income growth exceeding 1.5x CRK's 303.34%. David Dodd would verify competitive advantages.
1299.82%
Net margin growth exceeding 1.5x CRK's 188.51%. David Dodd would verify competitive advantages.
2595.00%
EPS growth exceeding 1.5x CRK's 308.70%. David Dodd would verify competitive advantages.
2595.00%
Diluted EPS growth exceeding 1.5x CRK's 308.70%. David Dodd would verify competitive advantages.
-0.18%
Share count reduction while CRK shows 0.00% change. Joel Greenblatt would examine strategy.
No Data
No Data available this quarter, please select a different quarter.